Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Insights, Epidemiology and Market Forecast, 2027 - ResearchAndMarkets.com

Research and Markets
Posted on: 05 Dec 18

The "Chemotherapy-Induced Peripheral Neuropathy (CIPN) - Market Insights, Epidemiology and Market Forecast" drug pipelines has been added to ResearchAndMarkets.com's offering.

The Chemotherapy-Induced Peripheral Neuropathy (CIPN) - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of CIPN in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China.

The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Chemotherapy-Induced Peripheral Neuropathy from 2016 to 2027 segmented by eight major markets. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Chemotherapy-Induced Peripheral Neuropathy Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Pipeline Analysis
  • Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Chemotherapy-Induced Peripheral Neuropathy Report Key Strengths

  • 10 Years Forecast
  • G8 Coverage
  • Epidemiology Segmentation
  • Key Cross Competition
  • Market Size by Therapies
  • Drugs Uptake

Chemotherapy-Induced Peripheral Neuropathy Report Assessment

  • Pipeline Product Profiles
  • Key Products and Key Players
  • Market Drivers and Barriers

Key Topics Covered:

1. Key Insights

2. Chemotherapy-Induced Peripheral Neuropathy: Market Overview at a Glance

3. Chemotherapy-Induced Peripheral Neuropathy: Disease Background and Overview

4. Epidemiology and Patient Population

5. Country Wise-Epidemiology of CIPN

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. Unmet Needs

8. Emerging Therapies

9. Chemotherapy Induced Peripheral Neuropathy: G8 Market Analysis

10. United States: Market Outlook

11. EU-5 countries: Market Outlook

12. Japan Market Outlook

13. China Market Outlook

14. Market Drivers

15. Market Barriers

16. Appendix

Companies Mentioned

  • Achelios Therapeutics
  • Apollo Endosurgery
  • Asahi Kasei Pharma
  • ChromaDex
  • DARA BioSciences
  • Laboratorios Dr. Esteve S.A.
  • MediciNova
  • Relief Therapeutics
  • Solasia/PledPharma
  • WEX Phamaceuticals

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vrp9d3/global?w=4.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181205005843/en/

Business Wire
www.businesswire.com

Last updated on: 05/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.